Health Canada
- Status: approved
🇨🇦 Heplisav -B in Canada
Heplisav -B (Heplisav -B) regulatory status in Canada.
Marketing authorisation
Heplisav -B in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Heplisav -B approved in Canada?
Yes. Health Canada has authorised it.
Who is the marketing authorisation holder for Heplisav -B in Canada?
National Heart, Lung, and Blood Institute (NHLBI) is the originator. The local marketing authorisation holder may differ — check the official source linked above.